Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Bullish on Elastic NYSE ESTC with Increased Price Target

Elaine Mendonca by Elaine Mendonca
March 1, 2024
in Breaking News
0
Bitcoin crypto on laptop
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

Rosenblatt analyst Blair Abernethy is bullish on Elastic (NYSE: ESTC), maintaining a Buy rating and increasing the price target to $136 as of March 1, 2024. Elastic, a leading software company, exceeded expectations in Q3 FY2024 with a 19.4% year-over-year revenue growth to $328 million.

Various analysts have provided price targets for Elastic, averaging at $125.76 with a high forecast of $185.00. Barron’s also reports an average price target of $125.95 based on 26 ratings. Elastic N.V., known for Elastic Search and Elastic Stack, offers open-source search and analytics engine services through products like Elasticsearch and Kibana.

The stock has displayed significant growth, boasting a return of +124.88% over the past year.

Elastic NV (ESTC) Stock Price Surges During Regular Trading Hours Despite Pre-Market Decline

On March 1, 2024, Elastic NV (ESTC) experienced a significant increase in its stock price, with shares rising by $5.45, or 4.30%, since the market last closed. This brought the closing price of ESTC shares to $133.81, trading near the top of its 52-week range and above its 200-day simple moving average.

Despite the positive momentum during regular trading hours, ESTC saw a sharp decline in pre-market trading, with the stock dropping by $19.21. This sudden decrease may have been influenced by various factors such as market volatility, economic indicators, or company-specific news.

Investors and analysts will be closely monitoring ESTC’s performance throughout the day to see if the stock can recover from the pre-market losses or if further declines are on the horizon. It is essential to consider the overall market conditions and company fundamentals when evaluating stock performance and making investment decisions.

ESTC Stock Shows Promising Revenue Growth and Reduced Losses in Recent Financial Results

On March 1, 2024, ESTC stock showed promising performances as the company reported strong financial results for the past year and the most recent quarter. According to data from CNN Money, ESTC’s total revenue for the past year was $1.07 billion, representing a significant increase of 23.96% compared to the previous year. In the most recent quarter, total revenue stood at $310.61 million, showing a 5.74% increase from the previous quarter.

Despite the positive revenue growth, ESTC reported a net income of -$236.16 million for the past year, marking a decrease of 15.85% compared to the previous year. However, in the most recent quarter, the company managed to reduce its net loss to -$24.80 million, representing an impressive increase of 48.88% from the previous quarter.

Earnings per share (EPS) for ESTC also showed a mixed performance. The company reported an EPS of -$2.47 for the past year, which was a decrease of 12.0% compared to the previous year. However, in the most recent quarter, the EPS improved to -$0.25, showing a significant increase of 49.46% from the previous quarter.

Overall, ESTC’s stock performances on March 1, 2024, reflected a company that is making progress in increasing its revenue and reducing its losses. Investors may view the positive revenue growth and improving net income and EPS as encouraging signs that ESTC is on the right track towards profitability.

Tags: ESTC
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Financialization

Analyst Maintains Buy Rating on Emerald Holding with Revised Price Target

Finance_ Chart Down

Analyst Adjusts Price Target for MVB Financial Diverse Opinions in the Financial Industry

Finances

Analyst Adjusts Price Target for Bakkt Holdings Maintains Buy Rating

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com